Annual report pursuant to Section 13 and 15(d)

Equity Incentive Plans & Stock-Based Compensation - Stock Options (Details)

v3.23.1
Equity Incentive Plans & Stock-Based Compensation - Stock Options (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Options      
Outstanding as of beginning of period (in shares) 16,960 21,191 21,471
Granted (in shares) 0 1,023  
Exercised (in shares) (2,981) (269)  
Forfeited or expired (in shares) (1,250) (1,034)  
Outstanding as of end of period (in shares) 16,960 21,191 21,471
Options vested and expected to vest as of end of period (in shares) 16,960 21,191  
Vested and exercisable as of end of period (in shares) 11,000 9,361  
Weighted-Average Exercise Price      
Outstanding as of beginning of period (in usd per share) $ 0.58 $ 0.33  
Granted (in usd per share) 0 6.69  
Exercised (in usd per share) 0.41 1.35  
Forfeited or expired (in usd per share) 1.60 1.09  
Outstanding as of end of period (in usd per share) 0.54 0.58 $ 0.33
Options vested and expected to vest as of end of period (in usd per share) 0.54 0.58  
Vested and exercisable as of end of period (in usd per share) $ 0.65 $ 0.56  
Weighted-Average Remaining Contractual Term in years 7 years 3 months 18 days 8 years 2 months 12 days 9 years 3 months 18 days
Additional Disclosures      
Aggregate intrinsic value of options outstanding $ 24.4 $ 153.2  
Aggregate intrinsic value of options exercised 10.9 $ 1.0  
Weighted-average grant date fair value of options granted (in usd per share)   $ 3.58  
Grant date fair value of options vested $ 1.9 $ 1.5